Renaissance Capital Partners
VC Fund
London, United Kingdom
Renaissance Capital Partners is a private company established in 2008 to invest funds in high-growth, innovative, and entrepreneurial businesses and also built environment projects.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Renaissance Capital Partners invests in
Health CareBiotechnologyTherapeuticsFinancial ServicesSaaS
Stages Renaissance Capital Partners invests in
Venture - Series UnknownSeedSeries BSeries AConvertible Note
Countries Renaissance Capital Partners invests in
United KingdomIreland
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Park
|
|||
Mark Randall
|
|||
Thomas Nicholls
|
|||
Investment Focus
Industry
- Health Care 7 (23%)
- Biotechnology 4 (13%)
- Therapeutics 3 (10%)
- Financial Services 3 (10%)
- SaaS 2 (7%)
Stage
- Venture - Series Unknown 9 (30%)
- Seed 8 (27%)
- Series B 2 (7%)
- Series A 1 (3%)
- Convertible Note 1 (3%)
Country
- United Kingdom 15 (50%)
- Ireland 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Adam Park
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email | |
|
Mark Randall
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
|
Thomas Nicholls
CFO
|
CFO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TC BioPharm
|
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life.TC BioPharm is a clinical development company with a cell-based product pipeline capable oftreating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients. | Venture - Series Unknown / Jan 19, 2021 | |
Creativity Software
|
Creativity Software provides location-based services (LBS) for mobile units. It offers LBS applications for mobile and Internet technologies, which include TransportWise, a vehicle tracking and fleet management platform for service providers and mobile operators to offer software as a service for their enterprise, and small and medium-sizedenterprises customers; FamilyWise, a family finder solution that tracks the mobile phones of the people it locates using the infrastructure of the mobile operator and enables users to locate friends or family members; and TravelWise, a travel content mobilization platform that delivers city guide information to customers, and allows users to search the rough guides content database and get information on travel spots in Europe. The company also provides WorkforceWise, a lone worker protection and field staff management solution that enables companies to know where their employees are or where they have been, as a protection enhancement system for lone workers or keeping track of their business travel; BuddyWise, a friend finder and social networking solution, which allows end user customers to share their location with friends, find where their friends are and/or get alerts when friends are nearby; and AdvertWise, a location-based mobile advertising solution for mobile operators offering a hosted mobile marketing service to enterprise customers. In addition, it offers LBS development, application hosting and management, technology transfer, and consultancy services. The company serves mobile network operators, service providers, enterprises, and mobile device manufacturers. Creativity Software Ltd. was founded in 2001 and is based in Kingston-upon-Thames, the United Kingdom. | Venture - Series Unknown / Dec 16, 2020 | |
Houst
|
Houst (previously Airsorted) is a short-let host management service that increases yields and handles everything from listing creation and pricing optimisation to the cleaning, laundry and keys. Their mission is to build a global platform that makes it easy to share your home - hassle-free hosting for everyone.Airsorted was founded in 2015 andis based in London, U.K. | Venture - Series Unknown / Sep 22, 2020 | |
Azadyne
|
Azadyne’s novel approach to treating autoimmune disease focuses on an unexplored pathway in the body and is based on research conducted at Trinity by Associate Professor in Biochemistry Vincent Kelly, Professor of Synthetic Chemistry Professor Stephen Connon and assistant Professor in Chemistry John Michael Southern. | Venture - Series Unknown / Sep 03, 2020 | |
AMTE Power
|
AMTE Power partners with niche customers, enabling them to scale and transfer emerging new cell technologies to manufacture. Its business involves the transfer of developed ‘pilot scale’ processes to its facility. The company also work with research groups and pilot scale facilities in the earlier stages of invention to aid with design formanufacture.AMTE Power has has secured commercial projects along with Government backed projects to research and develop the next generation of batteries. | Venture - Series Unknown / Aug 19, 2020 | |
Concured AI
|
CONCURED is a marketing agency that specializes in content marketing and technology. It uses artificial intelligence to help content marketers understand what topics their audience are engaging with, what they should create content on next, and where to promote it to maximize ROI. It provides competitor insight, social insight, and industry insightto create content. The company’s predictive content algorithm uses artificial intelligence to identify content gaps that are trending upwards in popularity but are yet to be exploited and its platform the highlights those gaps in context providing users with their next content ideas that will engage audience and cut through the noise.CONCURED was founded by Tom Salvat in 2015 and is headquartered in London, England. | Seed / Jul 14, 2020 | |
Better.co.uk
|
Trussle is a free online mortgage broker that's making mortgages fairer for everyone.Trussle has taken the mortgage process online, removing the time, hassle and costs involved in securing a mortgage. Trussle is completely free for customers and receives a fee from the lender once the mortgage was completed.Trussle is a trading style ofTrussle Lab Ltd, which is an appointed representative of Mortgage Advice Bureau Limited and Mortgage Advice Bureau (Derby) Limited which is authorized and regulated by the Financial Conduct Authority. | Series B / Jun 11, 2020 | |
Capdesk
|
Capdesk is an equity management platform helping companies manage cap tables, shareholder registers, and employee shares. It accelerates its customer's company growth by eliminating admin time to focus on core business tasks. Capdesk streamlines the equity management by automatically updating cap tables, statutory registers, and variousmodelings. Digital, end-to-end share issuance transfers, splits, consolidations, and cancellations can be performed seamlessly on the platform. With the equity information stored on the platform, clients can align stakeholders by giving them easy access to ownership information, share certificates, option vesting schedules, investment amounts, and latest values.The London, England-headquartered company was established in 2015. | $3.7M / Series A / Apr 23, 2020 | |
|
TC BioPharm
|
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life.TC BioPharm is a clinical development company with a cell-based product pipeline capable oftreating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients. | Venture - Series Unknown / Oct 31, 2019 | |
|
AMTE Power
|
AMTE Power partners with niche customers, enabling them to scale and transfer emerging new cell technologies to manufacture. Its business involves the transfer of developed ‘pilot scale’ processes to its facility. The company also work with research groups and pilot scale facilities in the earlier stages of invention to aid with design formanufacture.AMTE Power has has secured commercial projects along with Government backed projects to research and develop the next generation of batteries. | Venture - Series Unknown / Sep 24, 2019 | |
| See all 30 investments → | |||
Co-Investors
QVentures
2 deals together
500 Global
1 deal together
Aerion Partners
1 deal together
ACF Investors
1 deal together
Ascension
1 deal together
Genetix Biotherapeutics Inc.
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
112,472 investors
FinTech Investors
47,630 investors
Health Care Investors
47,147 investors
Financial Services Investors
29,276 investors
Biotech Investors
23,541 investors
Biotechnology Investors
20,889 investors
SaaS VC Funds
69,112 investors
FinTech VC Funds
31,727 investors
Health Care VC Funds
35,356 investors
FAQ
What does Renaissance Capital Partners invest in?
Renaissance Capital Partners invests primarily in Health Care, Biotechnology and Therapeutics startups, most often at Venture - Series Unknown and Seed stage. Most of the 30 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Renaissance Capital Partners?
Public channels for Renaissance Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Renaissance Capital Partners?
The team at Renaissance Capital Partners includes Adam Park (Chief Operating Officer), Mark Randall (Chief Executive Officer) and Thomas Nicholls (CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
